Headline RoundupNovember 18th, 2020

Perspectives: Moderna and Pfizer Announce Progress on COVID-19 Vaccines

Coronavirus, Coronavirus Vaccine, Moderna, Pfizer, White House, Anthony Fauci

Summary from the AllSides News Team

Pharmaceutical companies Moderna and Pfizer have both announced COVID-19 coronavirus vaccines that are reportedly about 95% effective. Both companies will soon apply for an emergency use authorization from the Food and Drug Administration. Most voices reacting to the news came from left- and center-rated outlets. Voices in left-rated outlets tended to be more cautious about the new vaccines, arguing that they would not offer a quick end to the pandemic by themselves. Voices in some right-rated outlets were more celebratory and credited the Trump administration.

Featured Coverage of this Story

From the Left

Sorry, America. Vaccines won’t end the pandemic anytime soon.

The Philadelphia Inquirer

See rating details

The Philadelphia Inquirer

Opinion

With more than 240,000 Americans dead from the COVID virus and far more hospitalized, our country is desperate for a vaccine that prevents serious cases. Billions of dollars in taxpayer money are being spent to put a stop to the virus, yet drug companies are using predominantly mild cases that produce cold-like symptoms, not infections or serious cases, to test the efficacy of their vaccines. Based on the reviews of trial protocols for seven leading vaccine candidates, including those from Moderna and Pfizer, the British Medical Journal (BMJ) wrote last...

Open on The Philadelphia Inquirer

Possible Paywall

From the Center

Rebuilding public trust will instill COVID-19 vaccine confidence

The Hill

See rating details

The Hill

Opinion

Moderna’s 94.5 percent vaccine efficacy rate brings renewed hope that a preventative therapy to reduce the spread of COVID-19 may be close at hand. This news is especially welcome as cases continue to spike across the country. But unless the American people trust it (or any of the other vaccines currently under development for that matter), nothing will change.

Only half of the American adults would receive a coronavirus vaccine if it were available today. That number is down precipitously from over 70 percent in May. Even more startling, a...

Open on The Hill

From the Right

Light at the end of the COVID-19 tunnel: Fantastic vaccine news

New York Post (News)

See rating details

New York Post (News)

Opinion

At last, light at the end of the COVID-19 tunnel: At least two highly effective vaccines should begin distribution before year’s end.

Moderna this week followed Pfizer in announcing plans to have a vaccine on the market by the end of December, and other companies are likely to soon follow.

US Health Secretary Alex Azar expects enough doses to vaccinate 20 million Americans before Jan. 1, with a real hope of universal US vaccination by mid-2021.

Thank President Trump’s Operation Warp Speed for not only funding research and the development...

Open on New York Post (News)

More headline roundups